Published in Medicine and Law Weekly, October 10th, 2008
As the CFC to HFA transition deadline for pressurized metered dose inhalers (MDIs) approaches, Flunisolide, an existing CFC based inhaled corticosteroid (ICS) branded as Aerobid(R), has been reformulated with a non ozone depleting propellant to transition through the CFC phase out. A notable change in Forest's Flunisolide HFA product will be the integration of the AEROCOUNT Dose Indicator to remind patients how much medication remains in their inhaler.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.